Background: Candida species are among the top 10 most frequently isolated nosocomial bloodstream pathogens in Europe. In particular, in neonatal intensive care units (NICUs) Candida infections are an emerging concern because of the increasing incidence, the related high morbidity and mortality rates reported. Moreover, the epidemiology of Candida infection rapidly changed in these years leading to the selection of less sensitive strains and species. Surveillance studies are mandatory to identify the local distribution of species, their antifungal susceptibility profiles and the emergence of resistance strains. Material/methods: From December 2012 we performed a cohort prospective surveillance study in our NICU, collecting weekly nasal and rectal swabs. Swabs were placed on Sabouraud agar. Candida growth on agar plates was confirmed by microscopic observation. Furthermore, Candida spp. was identified through Candida chromogenic agar (Candida chromogenic agar, Laboratorios Conda) and API® 20C AUX (Biomérieux). The first isolated non-C.albicans Candida (NCAC) species from colonized patients were tested with the main antifungal agents (YeastOne® Y010 Thermo Fisher Scientific) and the obtained MIC values were read according to CLSI. Results: From December 2012 to June 2016 we enrolled 874 neonates and analyzed respectively 2014 nasal and rectal swabs. 20/2014 (0,99%) of nasal swabs and 128/2014 (6,35%) of rectal swabs tested positive for Candida spp. The species distribution is showed in the Graph 1. 89/874 (10,18%) neonates tested positive at least in one swab. 59 isolates of NCAC species were tested with the main antifungal agents. All the tested strains were susceptible to echinocandins and amphotericin B. The susceptibility patterns for azoles are shown in the Table 1. Conclusions: Our study confirm the rule of surveillance in the prevention and control of Candida spp. healthcare related infections especially in an high risk ward such as NICU. In particular, in our NICU fluconazole prophylaxis is administered according to standard protocols from 2009.Antifungal susceptibility testes allowed to identify resistant and mutant strains whom acquired resistance so to obtain both clinical and epidemiological data promptly.
Geraci, D., Vecchio, D., Graziano, G., Saporito, L., Insinga, V., Maida, C., et al. (2017). Impact of Candida species colonization and azoles resistance in a neonatal intensive care unit. In Final Programme European Congress of Clinical Microbiology and Infectious Diseases Vienna, Austria 22 – 25 April 2017.
|Autori:||Geraci, D.; Vecchio, D.; Graziano, G.; Saporito, L.; Insinga, V.; Maida, C.; Torregrossa, M.; Vitale, F.; Corsello, G.; Giuffre, M.|
|Titolo:||Impact of Candida species colonization and azoles resistance in a neonatal intensive care unit|
|Data di creazione:||2017-04-25|
|Nome del convegno:||ECCMID 2017|
|Luogo del convegno:||Vienna|
|Anno del convegno:||22-25 Aprile 2017|
|Numero del convegno:||27th|
|Data di pubblicazione:||2017|
|Numero di pagine:||1|
|Citazione:||Geraci, D., Vecchio, D., Graziano, G., Saporito, L., Insinga, V., Maida, C., et al. (2017). Impact of Candida species colonization and azoles resistance in a neonatal intensive care unit. In Final Programme European Congress of Clinical Microbiology and Infectious Diseases Vienna, Austria 22 – 25 April 2017.|
|Tipologia:||0 - Proceedings (TIPOLOGIA NON ATTIVA)|
|Appare nelle tipologie:||0 - Proceedings (TIPOLOGIA NON ATTIVA)|